The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., & Glass, D. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1009 · Cited by 1,583
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., & Goldberg, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0610com · Cited by 1,539 · cited 1×
“Muscle atrophy is a debilitating consequence of multiple severe diseases, including diabetes, renal failure, advanced cancer and sepsis [1].”
BackgroundSkeletal muscle hypertrophy and atrophy signaling pathways
Glass, D. J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.018 · Cited by 1,106 · cited 1×
“101 which blocks upregulation of MAFbx andMuRF1 during skeletal muscle atrophy [11].”
BackgroundBentzinger, C. F., Romanino, K., Cloëtta, D., Lin, S., Mascarenhas, J. B., Oliveri, F., Xia, J., Casanova, E., Costa, C. F., Brink, M., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.10.002 · Cited by 640 · cited 1×
“Mice with muscle-specific ablation of mTOR display a progressive muscular dystrophy phenotype [15].”
BackgroundPatterns of gene expression in atrophying skeletal muscles: response to food deprivation
Jagoe, R. T., Lecker, S. H., Gomes, M., & Goldberg, A. L. (2002) · The FASEB Journal · doi:10.1096/fj.02-0312com · Cited by 344
Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo.
Shadfar, S., Couch, M. E., McKinney, K. A., Weinstein, L. J., Yin, X., Rodríguez, J. E., Guttridge, D. C., & Willis, M. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.563032 · Cited by 98 · cited 1×
“Resveratrol also has been reported to improve skeletal muscle atrophy from the influence of certain catabolic conditions, including diabetes [26], mechanical unloading [29], muscular dystrophy [30], and cancer [31].”
BackgroundMagee, P., Pearson, S., Whittingham-Dowd, J., & Allen, J. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.09.005 · Cited by 65
Cited by
Role of Inflammation in Muscle Homeostasis and Myogenesis
Costamagna, D., Costelli, P., Sampaolesi, M., & Penna, F. (2015) · Mediators of Inflammation · doi:10.1155/2015/805172 · Cited by 534
Cancer cachexia: molecular mechanisms and treatment strategies
Setiawan, T., Sari, I. N., Wijaya, Y. T., Julianto, N. M., Muhammad, J. A., Lee, H., Chae, J. H., & Kwon, H. Y. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01454-0 · Cited by 315
Inflammation and age-associated skeletal muscle deterioration (sarcopaenia)
Wang, J., Leung, K.-S., Chow, S. K.-H., & Cheung, W.-H. (2017) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2017.05.006 · Cited by 173
Mobley, C. B., Haun, C. T., Roberson, P. A., Mumford, P. W., Kephart, W. C., Romero, M. A., Osburn, S. C., Vann, C. G., Young, K. C., Beck, D. T., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0195203 · Cited by 112
Roberts, M. D., Haun, C. T., Mobley, C. B., Mumford, P. W., Romero, M. A., Roberson, P. A., Vann, C. G., & McCarthy, J. J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00834 · Cited by 107
Liao, Z.-Y., Chen, J.-L., Xiao, M.-H., Sun, Y., Zhao, Y.-X., Pu, D., Lv, A.-K., Wang, M.-L., Zhou, J., Zhu, S.-Y., et al. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.08.032 · Cited by 102
Wang, D., Sun, H., Song, G., Yang, Y., Zou, X., Han, P., & Li, S. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700941 · Cited by 102
Self-citationIL-15 Promotes Human Myogenesis and Mitigates the Detrimental Effects of TNFα on Myotube Development
O’Leary, M. F., Wallace, G. R., Bennett, A. J., Tsintzas, K., & Jones, S. W. (2017) · Scientific Reports · doi:10.1038/s41598-017-13479-w · Cited by 85
Kim, C., & Hwang, J.-K. (2020) · Nutrients · doi:10.3390/nu12041079 · Cited by 80
“The PI3K-Akt pathway is of high interest to achieve this purpose [10,11], since it”
BackgroundPomiès, P., Blaquière, M., Maury, J., Mercier, J., Gouzi, F., & Hayot, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0160092 · Cited by 70
“reverse C2C12 muscle cell atrophy caused by TNF-α through the inhibition of MurF1 expression [23,24], while resveratrol treatment of dexamethasone-atrophied L6 myotubes prevented muscle atrophy in association with repression of atrogin-1 and MuRF1 expression [25].”
BackgroundKim, Y., Kim, C.-S., Joe, Y., Chung, H. T., Ha, T. Y., & Yu, R. (2018) · Journal of Medicinal Food · doi:10.1089/jmf.2017.4108 · Cited by 69
Flavonoids: Nutraceutical Potential for Counteracting Muscle Atrophy
Kim, C., & Hwang, J.-K. (2020) · Food Science and Biotechnology · doi:10.1007/s10068-020-00816-5 · Cited by 45
Li, F., Li, X., Peng, X., Sun, L., Jia, S., Wang, P., Ma, S., Zhao, H., Yu, Q., & Huo, H. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4615 · Cited by 40
The Role of Sirtuins in Sarcopenia and Frailty
Anwar, M., Pradhan, R., Dey, S., & Kumar, R. (2023) · Aging and disease · doi:10.14336/ad.2022.0622 · Cited by 19
Metadata
- Authors
- Wang, D.-T., Yin, Y., Yang, Y.-J., Lv, P.-J., Shi, Y., Lu, L., & Wei, L.-B.
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 19
- Issue
- 2
- Pages
- 206-213
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W2042873218
- Cited by
- 175
- References
- 9
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.